Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
doi: 10.1007/s10753-023-01875-6 161 YangGNiJSLiYZhaMTuYLiK
Emerging role of GLP-1 agonists in obesity: A Comprehensive review of randomised controlled trials
Preliminary studies suggest that GLP-1 receptor agonists may offer benefits in neurological conditions like Alzheimers disease, substance use disorders, polycystic ovary syndrome (PCOS), and even non-alcoholic steatohepatitis (NASH)
Primary care physicians, internists, family medicine practitioners, nurse practitioners, and physician assistants who add structured weight loss programs to their practice are meeting a need that the healthcare system has systematically underserved for decades
US$ 26.32
US$ 29.14
US$ 28.48
US$ 23.49
US$ 22.01
US$ 26.09
